AG
GHDX

Advisor Group’s Genomic Health, Inc. GHDX Stock Holding History

Advisor Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,394
Closed -$95K – 5616
2019
Q3 		$95K Sell
1,394
-2
-0.1% -$137 ﹤0.01% 2923
2019
Q2 		$81K Sell
1,396
-17
-1% -$1.01K ﹤0.01% 3020
2019
Q1 		$99K Sell
1,413
-582
-29% -$43.2K ﹤0.01% 2880
2018
Q4 		$129K Buy
1,995
+516
+35% +$36.2K ﹤0.01% 2428
2018
Q3 		$104K Buy
1,479
+373
+34% +$21.8K ﹤0.01% 2729
2018
Q2 		$57K Buy
1,106
+661
+149% +$26.2K ﹤0.01% 2989
2018
Q1 		$13K Sell
445
-1,995
-82% -$66.2K ﹤0.01% 3948
2017
Q4 		$83K Buy
2,440
+981
+67% +$31.3K ﹤0.01% 2721
2017
Q3 		$47K Buy
1,459
+597
+69% +$18.8K ﹤0.01% 2996
2017
Q2 		$28K Buy
862
+159
+23% +$5.04K ﹤0.01% 3273
2017
Q1 		$23K Sell
703
-67
-9% -$1.98K ﹤0.01% 3299
2016
Q4 		$23K Buy
770
+197
+34% +$6.01K ﹤0.01% 3148
2016
Q3 		$17K Buy
573
+213
+59% +$5.93K ﹤0.01% 3273
2016
Q2 		$8K Buy
+360
New +$9.56K ﹤0.01% 3605

Advisor Group's GHDX Position: Q4 2019 in Review

Advisor Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 1,394 shares — an estimated $95K sold.

Advisor Group first reported a position in GHDX in Q2 2016 and held it in 14 quarters. The position peaked at $129K in Q4 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Advisor Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Advisor Group sold 1,394 Genomic Health, Inc. shares in Q4 2019, an estimated $95K.
  • Advisor Group first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 14 quarters.
  • Advisor Group's Genomic Health, Inc. position peaked at $129K in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.